PhaseBio Pharmaceuticals Inc. (PHAS) Slipped -5.4% or -0.61 To Price $10.69 On Thursday


PhaseBio Pharmaceuticals Inc. (PHAS) slipped -5.4% or -0.61 to $10.69. It is near 28636 shares traded, which is 15.62% compare to the average total volume 183372. The market cap of PHAS is $306.02 million. The year to date change is 255.05%. The 52 week price range is from $2.55 to $16.65. Price of PHAS have changed -3.21% during last week. It have changed -15.70% over last month, N/A N/A and 123.40% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PHAS is 12.01. It is 12.35% above current price. The 200-day Moving Averages for PHAS is 6.44. It is -39.76% below current price. The 52-week High is 16.65. It is 55.75% from the current price. The 52-week Low is 2.55. It is -76.15% from current price.

There are some statistics of PHAS. It is has market cap $306.02 million. The share outstanding is 28.63 million. The average volume is 183372. The percent of top 15 Institution holding is 29.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PHAS is -60.65%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PHAS is -47.42%.


Tags:

Share this post